All news

No shares sold: Alzamend Neuro (ALZN) requests withdrawal of a resale registration.

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

Alzamend Neuro, Inc. (ALZN) has requested the withdrawal of its Form S-1 registration for the resale of up to 98.4 million shares of common stock. The company stated that the registration never became effective and no shares were or will be sold under it. The withdrawal was prompted by SEC staff advising that the transaction structure was no longer viable for effectiveness.

Read original source

ALZN company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.